about
Aberrant Promoter Hypomethylation in CLL: Does It Matter for Disease Development?Hypoxia and Hypoxia-Inducible Factors in LeukemiasThe complexity of epigenetic diseasesRevisiting the case for genetically engineered mouse models in human myelodysplastic syndrome researchEpigenetic Guardian: A Review of the DNA Methyltransferase DNMT3A in Acute Myeloid Leukaemia and Clonal Haematopoiesis.DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodelingEpigenetics in normal and malignant hematopoiesis: An overview and update 2017.Cancer stem cell heterogeneity: origin and new perspectives on CSC targetingCis-perturbation of cancer drivers by the HTLV-1/BLV proviruses is an early determinant of leukemogenesis.Epigenetic regulation of epithelial-mesenchymal transitionThe genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemiaEpigenetic Control of Stem Cell Potential during Homeostasis, Aging, and DiseaseConserved motif VIII of murine DNA methyltransferase Dnmt3a is essential for methylation activityDNMT3A R882 Mutations Predict a Poor Prognosis in AML: A Meta-Analysis From 4474 PatientsDnmt3a Is a Haploinsufficient Tumor Suppressor in CD8+ Peripheral T Cell Lymphoma.Developmental and Thyroid Hormone Regulation of the DNA Methyltransferase 3a Gene in Xenopus Tadpoles.Identification of cell-type-specific mutations in nodal T-cell lymphomas.DNA methylation and hydroxymethylation in hematologic differentiation and transformation.PML-RARA requires DNA methyltransferase 3A to initiate acute promyelocytic leukemia.The Impact of DNA Methylation in Hematopoietic Malignancies.Promoter Hypomethylation and Expression Is Conserved in Mouse Chronic Lymphocytic Leukemia Induced by Decreased or Inactivated Dnmt3a.Genomic Profiling of Thyroid Cancer Reveals a Role for Thyroglobulin in Metastasis.Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies.Epigenetic Perturbations by Arg882-Mutated DNMT3A Potentiate Aberrant Stem Cell Gene-Expression Program and Acute Leukemia Development.Expression of immunoproteasome genes is regulated by cell-intrinsic and -extrinsic factors in human cancersEpigenetics of hematopoiesis and hematological malignancies.Massive and parallel expression profiling using microarrayed single-cell sequencing.MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia.DNA methyltransferases and their roles in tumorigenesis.VEGFA activates an epigenetic pathway upregulating ovarian cancer-initiating cells.Dnmt3a deletion cooperates with the Flt3/ITD mutation to drive leukemogenesis in a murine model.Dnmt3a haploinsufficiency cooperates with oncogenic Kras to promote an early-onset T-cell acute lymphoblastic leukemia.Bidirectional transcription of Linc00441 and RB1 via H3K27 modification-dependent way promotes hepatocellular carcinoma.Molecular Pathogenesis of Peripheral T Cell Lymphoma.Mutations in epigenetic modifiers in acute myeloid leukemia and their clinical utility.Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease.Mutations in NOTCH1 PEST-domain orchestrate CCL19-driven homing of Chronic Lymphocytic Leukemia cells by modulating the tumor suppressor gene DUSP22.Liganded Thyroid Hormone Receptors Transactivate the DNA Methyltransferase 3a Gene in Mouse Neuronal CellsDNA methylation in normal and malignant hematopoiesis.On the potential role of DNMT1 in acute myeloid leukemia and myelodysplastic syndromes: not another mutated epigenetic driver.
P2860
Q26738706-094E1B7F-842F-4C58-9173-A72754280E18Q26767167-E4A60F36-1274-48FF-98BD-D9B3F0E46122Q26784416-BAEF6B18-CD92-4BA3-96F6-D164F3D8DE33Q26859843-9CCB66EC-A096-4CCA-BA85-BE5A33DCB6ADQ30235316-5ACB9FCA-2F4F-49A3-A6DC-D67DF3EA9378Q30355347-FE33DAD6-94C7-4F29-8956-FE1F02BA2780Q33607609-061C235F-B724-49E1-A1BD-77672E7450AFQ33649230-61AE13F8-EA2E-4AA6-A210-D9CCF88F795CQ33759081-76C3DB65-766D-42C3-8CB0-EE999D88C8CCQ33764436-A3CFE07E-119D-475D-AB67-0DC07D13398FQ33796552-3524713B-7F79-4B90-9290-803EE0715490Q35747943-06FAE878-1590-46CD-A222-96E259A83EC3Q35965530-2FE6EF1C-A40A-404F-AA44-483F98F7AABFQ36009675-72B225C3-EA90-41B7-8641-88E4C217B9E8Q36149906-3E74F96E-DB34-44A2-9A73-53ED2D521711Q36173936-2D80F2A1-A90A-411B-B18C-20394F949AA3Q36269008-27EF3DF0-CBD8-439F-BCBC-6369C0342D65Q36395976-5A9EF78D-C210-410A-B9F2-4B9CBCAC39F0Q36430688-EDA1C558-ACE0-4D9F-BC6D-688DD5EC265AQ36724810-F89054AB-FAC0-4283-B903-17A4A669AD41Q36892794-5778AD20-F041-4594-ABDC-549C2EF229B9Q37005057-DCEB49B8-35D2-4A16-A3BA-38F83D5C307EQ37076434-57461B83-2331-4911-AD3A-46B5AE99B1C6Q37095702-627FCA5C-A8D6-45DD-B2B6-7A0B31896F75Q37278032-26F2F91E-FB31-426F-A0F0-DBFFBBE14D34Q37343797-1DBB4B17-B8F8-4325-81BB-2E3CE8F7B420Q37345329-57E2A4A8-1523-46D1-B7FF-6C87E0880B31Q37457356-BEE2E95C-BC49-4ED0-8962-BBD41C549D1BQ37597292-DA3450B2-C86F-4F40-92C6-99D91AC879A8Q37672753-6A13F2DC-10F9-4279-BB3C-67E0DF3070D8Q37688327-D4836664-9DF8-4544-ACF9-943B64D33162Q37733030-55084563-5476-4C99-97AA-15C07FB9FF06Q37745567-A0237506-DF76-412F-8A1A-F672FEB175F7Q38597997-79448C8B-398F-467A-A4D7-9BA6EEB43D80Q38703904-FFC3664D-5A60-4D6B-95C3-1F5F580AE7B5Q38721210-32BEE020-8FD6-4EEA-96A8-F6A54ECBA5C3Q38724344-C10DEF28-CEF9-4D4E-A7EA-17D6C79440BDQ38759329-C0012E6F-03AB-4440-920A-5C920E8D944CQ38760713-ED415319-A24E-4D20-9BDA-7944D9D251F1Q38777440-1D41A2DD-9D0C-47A3-ACFE-FB6BEDCEE7D9
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
DNMT3A in haematological malignancies.
@ast
DNMT3A in haematological malignancies.
@en
DNMT3A in haematological malignancies.
@nl
type
label
DNMT3A in haematological malignancies.
@ast
DNMT3A in haematological malignancies.
@en
DNMT3A in haematological malignancies.
@nl
prefLabel
DNMT3A in haematological malignancies.
@ast
DNMT3A in haematological malignancies.
@en
DNMT3A in haematological malignancies.
@nl
P2860
P356
P1476
DNMT3A in haematological malignancies.
@en
P2093
Liubin Yang
P2860
P2888
P304
P356
10.1038/NRC3895
P407
P577
2015-02-19T00:00:00Z
P5875
P6179
1039113899